Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 659.92 million compared to CNY 521.9 million a year ago. Revenue was CNY 659.92 million compared to CNY 521.9 million a year ago. Net income was CNY 113.49 million compared to CNY 84.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.2255 compared to CNY 0.1684 a year ago. Diluted earnings per share from continuing operations was CNY 0.2255 compared to CNY 0.1684 a year ago.